On January 24, 2012, the Southern District of New York preliminarily approved a settlement in In Re: Novartis Wage and Hour Litigation, which will pay pharmaceutical sales representatives (“Sales
Continue Reading Pharmaceutical Sales Representatives Get $99 Million In Overtime From Novartis
Pharmaceutical Sales Representatives
Further Confusion — The Split in Authority Regarding the Exempt Status of Pharmaceutical Sales Representatives
By Fox Rothschild LLP on
In early January, I posted an entry regarding the exempt status of pharmaceutical sales representatives. In the past several months, there have been several significant developments with respect to this…
Continue Reading Further Confusion — The Split in Authority Regarding the Exempt Status of Pharmaceutical Sales Representatives